| GERON CORP. (DEL.) DL-001 |
| USA |
| Gesundheit |
| US3741631036 / 902213 |
| GON (Frankfurt) / GERN (NASDAQ) |
| FRA:GON, ETR:GON, GON:GR, NASDAQ:GERN |
| - |
| https://www.geron.com/ |
|
Geron Corporation is a biopharmaceutical company d..
>Volltext.. |
| 697.87 Mio. EUR |
| 579.06 Mio. EUR |
| 141.63 Mio. EUR |
| -65.7 Mio. EUR |
| -75.8 Mio. EUR |
| -0.11 EUR |
| 215.15 Mio. EUR |
| 68.56 Mio. EUR |
| -153.55 Mio. EUR |
| 6.06 |
| 10790.67% |
| 63.55% |
| - |
| - |
| - |
| - |
| GERON |
| 22.10.25 |
|